This webinar offers a deep dive into the significant role of structural and functional characterization in demonstrating biosimilarity and comparability using mass spectrometry. Our discussion also highlights the challenges faced by professionals in implementing the latest advancements in mass spectrometry due to varying levels of expertise, complex data interpretation, and reporting. These challenges often result in lower productivity and reduced return on investment, issues that are efficiently addressed by Protein Metrics’ software solutions.

The webinar features insights from industry experts who outline the capabilities of the Byosphere platform in managing data in a regulated environment, ensuring compliance, and enhancing data interpretation workflows. By integrating innovative mass spectrometry technologies such as high-resolution analyzers and efficient ion sources, Byosphere facilitates sensitive and comprehensive analysis essential for ensuring the safety and quality of biopharmaceutical products. The platform not only supports rigorous regulatory requirements but also improves the scalability and efficiency of biosimilar development workflows, making it an invaluable tool for professionals in the biosimilar industry.